Clinical Trial Update: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Intravenous Ibuprofen 400 and 800 mg Every 6 Hours in the Management of Postoperative Pain. [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind trial evaluating intravenous ibuprofen (400 mg and 800 mg every 6 hours) for postoperative pain management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Yi Feng, MD | Conditions: Ibuprofen, Nonsteroidal Anti-inflammatory Drug | Phase 3 | Status: UNKNOWN